The University of Texas at Austin offers a simultaneous Pharm.D./Ph.D. program. It will take approximately three years after the Pharm.D. program to complete the Ph.D. After the fall semester of your second year, administrators invite qualified students to enroll in the first phase of the simultaneous program. You must submit your scores in the Graduate Record Examination (GRE), college transcripts, a personal statement and recommendation letters. In completing this program, you will take courses in subjects such as biopharmaceutics, pharmacology principles, pharmaceutics and health-care systems.
The University of Arizona's College of Pharmacy in Tucson offers a Ph.D. in either pharmaceutical sciences or pharmacology and toxicology. The priority deadline for applications is January 1 for domestic students and December 1 for international students. The department only accepts students for the fall semester. To apply, send an application form, GRE scores, three letters of recommendation, transcripts and a personal statement. If English is not your first language, TOEFL scores are also expected. A few of the courses offered are pharmaceutical policy, bioethics and health care/health policy.
In addition to taking pharmaceutical-science courses, candidates in the University of Michigan's Ph.D. program must complete six credits outside this field and present two seminars before graduation. Applications and a resume are due in January. Some of the required courses are ethics, biopharmaceutics, drug disposition and pharmaceutical design.
The University of Iowa's College of Pharmacy offers both a Ph.D. and a joint Pharm.D./Ph.D. You can also earn a Global Health Certificate, attesting to your ability to tackle health-care problems in underserved communities in the U.S. or abroad. While the university accepts most of its candidates for the fall semester, applications may be considered for spring or summer. Scholarship opportunities are also available. Required courses range from principles of experimental therapeutics and fundamental genetics to biostatistics and clinical pharmacogenomics.